Colchicine in Atrial Fibrillation to Prevent Stroke

Summary

The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).

Timeline

Start

2014-11

Primary completion

2020-11-17

Completion

2020-11-17

Drugs

Indications